Boston Trust Walden Corp lowered its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 10.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 198,818 shares of the company’s stock after selling 22,045 shares during the period. Boston Trust Walden Corp’s holdings in Colgate-Palmolive were worth $18,075,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CL. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $42,000. Synergy Asset Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth $49,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the third quarter worth $53,000. Finally, Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at $64,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on CL. Raymond James reiterated an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Price Performance
CL opened at $87.05 on Tuesday. The firm has a market capitalization of $71.12 billion, a P/E ratio of 24.73, a PEG ratio of 3.61 and a beta of 0.44. The stock has a fifty day moving average of $91.35 and a 200-day moving average of $97.15. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company posted $0.87 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.74 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What is the NASDAQ Stock Exchange?
- How to Invest in Small Cap Stocks
- Why Invest in 5G? How to Invest in 5G Stocks
- These Are the Dividend Stocks Insiders Bought in January
- What is the MACD Indicator and How to Use it in Your Trading
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.